BioSig Technologies Files 2024 10-K, Details Preferred Stock
Ticker: STEX · Form: 10-K · Filed: Apr 15, 2025 · CIK: 1530766
| Field | Detail |
|---|---|
| Company | Biosig Technologies, Inc. (STEX) |
| Form Type | 10-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, financials, preferred-stock
TL;DR
BioSig 10-K filed: FY24 results in, preferred stock details out.
AI Summary
BioSig Technologies, Inc. filed its 10-K for the fiscal year ending December 31, 2024, reporting on its operations in electromedical apparatus. The filing details various series of preferred stock, including Series C, D, E, and F, and related party transactions as of December 31, 2024, and December 31, 2023. The company is incorporated in Delaware and its principal executive offices are located in Westport, CT.
Why It Matters
This 10-K filing provides investors with a comprehensive overview of BioSig Technologies' financial health and corporate structure for the fiscal year 2024, including details on its preferred stock and related party transactions.
Risk Assessment
Risk Level: medium — The filing contains details on preferred stock and related party transactions, which can introduce complexity and potential risks for common shareholders.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2023-12-31 — Prior Fiscal Year End (Comparison period for financial data)
Key Players & Entities
- BioSig Technologies, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 3845 (industry_code) — Standard Industrial Classification for Electromedical & Electrotherapeutic Apparatus
- DE (state) — State of Incorporation
- CT (state) — State of Business and Mail Address
- Series C Preferred Stock (security) — Mentioned in filing data
- Series D Preferred Stock (security) — Mentioned in filing data
- Series E Preferred Stock (security) — Mentioned in filing data
- Series F Preferred Stock (security) — Mentioned in filing data
FAQ
What is the primary business of BioSig Technologies, Inc.?
BioSig Technologies, Inc. operates in the Electromedical & Electrotherapeutic Apparatus industry, SIC code 3845.
What is the fiscal year end for this 10-K filing?
The fiscal year end for this 10-K filing is December 31, 2024.
Where are BioSig Technologies, Inc.'s principal executive offices located?
The principal executive offices are located at 55 Greens Farms Road, Westport, CT 06880.
What types of preferred stock are mentioned in the filing data?
The filing data mentions Series C, Series D, Series E, and Series F Preferred Stock, among others.
In which state is BioSig Technologies, Inc. incorporated?
BioSig Technologies, Inc. is incorporated in Delaware (DE).
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on April 15, 2025 regarding BioSig Technologies, Inc. (STEX).